OncoEng centres on a transformational and systems engineering approach Metastatic Bone Disease (MBD) in the spine using a framework combining advanced image-based modelling and cutting edge manufacturing to enable an optimised, metamaterial-based minimally invasive implant (MII). Long-term patient impact will be enabled by partnership with the industry and healthcare sectors, as well as other globally leading academic units.
Researchers will develop new approaches to patient imaging and computer modelling, enabling them to track tumour development in the spine over time and how it might be weakening individual vertebrae.
The information would be compared with the loading on the spine, enabling clinicians to predict which of the vertebrae is at risk of fracturing.
Finally a new medical device will be developed to enable treatment of vertebrae at a high-risk of collapse to be supported by an implant inserted into the spine using minimally invasive techniques.
A minimally invasive device (figure below) will be optimally designed using a multiscale approach; the concept will be tested both computationally and experimentally going beyond standard in vitro test methods. This will include an initial, novel in silico trials framework and adverse scenarios which are more likely to induce fracture.
A new type of minimally invasive vertebrae implant
A minimally invasive device (figure right) will be optimally designed using a multiscale approach; the concept will be tested both computationally and experimentally going beyond standard in vitro test methods.
This will include an initial, novel in silico trials framework and adverse scenarios which are more likely to induce fracture.
“ This project allows us to expand our expertise in the analysis, optimisation and 3D printing of structural metamaterials. By working as part of the multidisciplinary team we aim to apply the new approaches and knowledge to improve the quality of life of late-stage cancer suffers.
We will also be able to apply some of these new approaches back into the aerospace and mechanical engineering sectors where advanced meta-materials have a wide range of potential applications.”
Training Lead and Co-investigator of the OncoEng collaboration at Imperial College
The 6 scientific objectives that provide an integrated approach to realising the overall aims and vision of OncoEng are:
Latest News
Using statistical shape models to develop generalised models of vertebrae
Within OncoEng, the team at UCL aims to develop state-of-the-art imaging and computational tools to predict the growth of metastatic lesions and how these can result in fractures in the spine. This involves a variety…
Metamaterials Explored: Our Experience at the 2023 UK Metamaterials Network Conference
This June, Ryan and I had the privilege of attending the UK Metamaterials Network conference at the scenic Wotton House. Over three insightful days, we delved deep into the diverse world of metamaterials, exploring their…
Exploring Metastatic Bone Disease Through Patient Narratives
As a mechanical engineer looking to develop methodologies to characterise spinal biomechanics and its perturbation due to metastatic bone disease (MBD), attending the OncoEng Patient Day was an eye-opening experience. This event provided an invaluable…
Birmingham Med-Tech Innovation Expo 2023
Blog written by Yash Karade and Aamena Lakdawala We bid farewell to Leeds on the morning of 7th June 2023 as we started our journey to the MedTech Expo in Birmingham. It was surely a…
World Cancer Day
The Leeds Cancer Research Centre will be delivering a mini-conference as part of World Cancer Day on the 3 rd February (World Cancer Day is actually on 4th Feb). OncoEng is very supportive of the…
OncoEng Quarterly Meeting
Great OncoEng Quarterly get together last week. The Management Board Meeting in the morning was eagerly attended by all the researchers and academics. In the afternoon we were joined by Dr Sherron Furtado, Craig Gerrand, Sarah Astill and David Lunn to…